S100A4
Showing 1 - 25 of >10,000
Psoriasis Trial in Sohag (skin biopsy)
Not yet recruiting
- Psoriasis
- skin biopsy
-
Sohag, EgyptSohag university Hospital
Sep 21, 2023
Group A Streptococcal Infection Trial in Edmonton (p*17-K4S2 (25 µg/mL), J8-K4S2 (100 µg/mL), p*17-K4S2 (50 µg/mL))
Not yet recruiting
- Group A Streptococcal Infection
- p*17-K4S2 (25 µg/mL)
- +4 more
-
Edmonton, Alberta, CanadaUniversity of Alberta Hospital
Jul 26, 2022
Rheumatoid Arthritis Trial in Chi?inau (AP1189, 60 mg, AP1189, 80 mg, AP1189, 100 mg)
Recruiting
- Rheumatoid Arthritis
- AP1189, 60 mg
- +3 more
-
Chișinău, Moldova, Republic ofTimofei Mosneaga Republican Clinical Hospital
Jan 5, 2023
HIV-1-infection Trial in United States (426c.Mod.Core-C4b 30 mcg, 426c.Mod.Core-C4b 100 mcg, 426c.Mod.Core-C4b 300 mcg)
Recruiting
- HIV-1-infection
- 426c.Mod.Core-C4b 30 mcg
- +3 more
-
Birmingham, Alabama
- +5 more
Jul 25, 2022
Myocardial Infarction, Acute Trial in Poland (Ferinject, Sodium Chloride 0.9% Inj)
Recruiting
- Myocardial Infarction, Acute
- Ferinject
- Sodium Chloride 0.9% Inj
-
Wrocław, Dolnośląskie, Poland
- +14 more
Feb 24, 2023
Asthma Trial in Worldwide (Tezepelumab, Placebo)
Recruiting
- Asthma
- Tezepelumab
- Placebo
-
Montgomery, Alabama
- +38 more
Aug 30, 2023
Rotator Cuff Tears, Rotator Cuff Injuries, Subacromial Impingement Trial in White City (Tranexamic Acid 100 MG/ML)
Recruiting
- Rotator Cuff Tears
- +3 more
- Tranexamic Acid 100 MG/ML
-
White City, Saskatchewan, CanadaDash & Reed Sports Medicine
Apr 28, 2021
NSCLC, Tumors Trial in Canada, Poland, Romania (Debio 1143, Avelumab)
Completed
- Carcinoma, Non-Small-Cell Lung
- Neoplasms
- Debio 1143
- Avelumab
-
Edmonton, Alberta, Canada
- +8 more
May 30, 2022
Refractory and/or Unexplained Chronic Cough Trial in Worldwide (BAY1817080, Placebo)
Completed
- Refractory and/or Unexplained Chronic Cough
- BAY1817080
- Placebo
-
Los Angeles, California
- +98 more
Jul 24, 2022
Essential Tremor Trial in Canada, United States (100 mg PRAX-944, 60 mg PRAX-944, Placebo)
Active, not recruiting
- Essential Tremor
- 100 mg PRAX-944
- +3 more
-
Birmingham, Alabama
- +38 more
Jan 23, 2023
Metastatic NSCLC Trial in Worldwide (Volrustomig, Pembrolizumab, Carboplatin)
Not yet recruiting
- Metastatic Non-small Cell Lung Cancer
- Volrustomig
- +4 more
-
Rosario, Argentina
- +51 more
Aug 2, 2023
Respiratory Syncytial Virus, Human Metapneumovirus Trial in Worldwide (mRNA-1345, mRNA-1365, Placebo)
Recruiting
- Respiratory Syncytial Virus
- Human Metapneumovirus
- mRNA-1345
- +3 more
-
Andalusia, Alabama
- +72 more
Feb 15, 2023
Pain Trial in Harrow (Ibuprofen, Diclofenac, Methyl-salicylate / Menthol)
Completed
- Pain
- Ibuprofen
- +3 more
-
Harrow, Middlesex, United KingdomPAREXEL EPCU Northwick Park
Jan 11, 2021
Biological Availability Trial in Miami (Zavegepant 100mg non-enteric coated soft gel capsule, Zavegepant 100mg immediate release
Completed
- Biological Availability
- Zavegepant 100mg non-enteric coated soft gel capsule
- +3 more
-
Miami, FloridaSyneos Health Clinical Research Services, Llc
Nov 14, 2023
Spondylitis, Ankylosing Trial in Worldwide (CC-99677, Placebo)
Active, not recruiting
- Spondylitis, Ankylosing
- CC-99677
- Placebo
-
Flagstaff, Arizona
- +139 more
Dec 9, 2022
Severe Hypertriglyceridemia Trial in Worldwide (ARO-APOC3, Placebo)
Active, not recruiting
- Severe Hypertriglyceridemia
- ARO-APOC3
- Placebo
-
Beverly Hills, California
- +72 more
Nov 29, 2022
Allergy Trial in Worldwide (SQ tree SLIT-tablet, Placebo)
Recruiting
- Allergy
- SQ tree SLIT-tablet
- Placebo
-
Vienna, Austria
- +83 more
Dec 21, 2022
Alopecia Areata Trial in Worldwide (CTP-543, 8 mg BID, CTP-543, 12 mg BID, Placebo, BID)
Completed
- Alopecia Areata
- CTP-543, 8 mg BID
- +2 more
-
Phoenix, Arizona
- +62 more
Sep 28, 2022
Nasal Polyps Trial in Worldwide (Depemokimab (GSK3511294), Placebo)
Recruiting
- Nasal Polyps
- Depemokimab (GSK3511294)
- Placebo
-
Tucson, Arizona
- +79 more
Jan 19, 2023
COPD (COPD) Trial in Worldwide (BGF MDI HFO 320/14.4/9.6 µg, BGF MDI HFA 320/14.4/9.6 µg)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- BGF MDI HFO 320/14.4/9.6 μg
- BGF MDI HFA 320/14.4/9.6 μg
-
Phoenix, Arizona
- +96 more
Jan 23, 2023
Painful Diabetic Neuropathy Trial in Worldwide (trazodone/gabapentin 2.5/25 mg, trazodone/gabapentin 5/50 mg,
Completed
- Painful Diabetic Neuropathy
- trazodone/gabapentin 2.5/25 mg
- +4 more
-
Litomyšl, 570 01, Czechia
- +29 more
May 26, 2021